Edition:
United States

Biotechnology & Medical Research

Adalta says FY net loss attributable A$2.8 mln vs loss of A$1.2 mln

Aug 21 (Reuters) - Adalta Ltd :FY net loss attributable to members A$2.8 million versus loss of A$1.2 million.FY revenue from ordinary activities $2 million versus $746,948.

3:22am EDT

Stonepine Capital Management Llc reports 13.7 percent passive stake in Apollo Endosurgery Inc

Aug 18 (Reuters) - Stonepine Capital Management LLC::Stonepine Capital Management Llc reports 13.7 percent passive stake in Apollo Endosurgery Inc as of August 11, 2017 - SEC filing‍​.

Friday, 18 Aug 2017 05:30pm EDT

‍Caxton Corp reports 5.3 pct passive stake in Agile Therapeutics Inc

Aug 18 (Reuters) - Agile Therapeutics Inc ::‍Caxton Corp reports 5.3 percent passive stake in Agile Therapeutics Inc as on August 9, 2017 - SEC filing​.

Friday, 18 Aug 2017 03:23pm EDT

Restructuring & Reorganization

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.